Omnaris
NDC Package 63402-701-01
Package Information
Omnaris is a medication used to treat symptoms of the nose (stuffiness or congestion, runny nose, itching, and sneezing) caused by seasonal and year-round nasal allergies. Marketed by Sunovion Pharmaceuticals Inc., this product is identified by NDC 63402-701 and is authorized under FDA application NDA022004.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63402 - Sunovion Pharmaceuticals Inc.
- 63402-701 - Omnaris
- 63402-701-01 - 1 POUCH in 1 CARTON / 1 BOTTLE, SPRAY in 1 POUCH / 120 SPRAY in 1 BOTTLE, SPRAY
- 63402-701 - Omnaris
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63402-701). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63402-701-01 identifies a specific commercial package of 1 pouch in 1 carton / 1 bottle, spray in 1 pouch / 120 spray in 1 bottle, spray of Omnaris, labeled by Sunovion Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sunovion Pharmaceuticals Inc. on March 01, 2008. The current certification is valid through December 01, 2019.
What are the primary indications for this medication?
This medication is used to treat symptoms of the nose (stuffiness or congestion, runny nose, itching, and sneezing) caused by seasonal and year-round nasal allergies. Ciclesonide works by reducing the swelling (inflammation) of the nasal passages. It belongs to the class of drugs known as corticosteroids.
How is this Sunovion Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63402070101. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.